News for hackers. Stuff that matters.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by marvin on Friday May 22, 2020 @01:06PM (#23274366)
Was this done in the study linked?

All doctors I’ve seen promote hydroxychloroquine have been adamant that it must be administered early in the disease’s progression in order to have any effect.

But most of the studies being performed that I’ve heard of, have explicitly been on late-stage patients. This includes the central EU study.

It would be tragic if the drug works when administered early, but all the studies have happened at a late stage, incorrectly disqualifying a treatment that can save many lives.

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by rsynnott on Friday May 22, 2020 @01:55PM (#23274974)
As mentioned in the paper they only include people where the drug was given within 48 hours after diagnosis.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by giardini on Friday May 22, 2020 @03:57PM (#23276232)
48 hours is two days! "48 hours after diagnosis" is NOT early treatment. See my earlier post!
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by Khelavaster on Friday May 22, 2020 @03:17PM (#23275825)
So, the time between when symptoms first started and up to 48 hours after patients' test results came back positive.